ChristopherDO'BrienMDPhD

Critical Care Medicine

Chief Medical Officer Kinaset Therapeutics

Dr. O'Brien is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

University of Pennsylvania Health SystemFellowship, Pulmonary Disease and Critical Care Medicine, 1995 - 1998
University of Pennsylvania Health SystemResidency, Internal Medicine, 1991 - 1994
Uconn School Of MedicineClass of 1991

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

PubMed

7 citations
Efficacy of budesonide/formoterol pressurized metered-dose inhaler versus budesonide pressurized metered-dose inhaler alone in Hispanic adults and adolescents with ast...
James Zangrilli, Lyndon E. Mansfield, Tom Uryniak, C.D. O'Brien
Annals of Allergy, Asthma & Immunology. 2011-09-01
96 citations
Antibodies against the first Ig-like domain of human platelet endothelial cell adhesion molecule-1 (PECAM-1) that inhibit PECAM-1-dependent homophilic adhesion block i...
Marian T. Nakada, Kunjlata M. Amin, Melpo Christofidou-Solomidou, Christopher D. O'Brien, Jing Sun
Journal of Immunology. 2000-01-01
166 citations
Involvement of human PECAM-1 in angiogenesis and in vitro endothelial cell migration
Gaoyuan Cao, Christopher D. O'Brien, Zhao Zhou, Samuel M. Sanders, Jordan N. Greenbaum
American Journal of Physiology. Cell Physiology. 2002-05-01

Journal Articles

Model‐Based Investigation of Inadequate Efficacy of Tesnatilimab, an Anti–Natural Killer Group 2 Member D Monoclonal Antibody, in Moderately to Severely Active Crohn D...
Jie Zhou PhD, Yan Xu MD, PhD, FCP, Yang Chen PhD, Jie Shao PhD, Yaming Su PhD, Zhenhua Xu MD, PhD, FCP, Honghui Zhou PhD, FCP, FAAPS, Christopher O'Brien PhD, MD, The Journal of Clinical Pharmacology, 5/17/2023
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis
Bruce E. Sands, M.D. https://orcid.org/0000-0001-5762-5042, William J. Sandborn, M.D., Remo Panaccione, M.D., Christopher D. O’Brien, M.D., Ph.D., Hongyan Zhang, Ph.D...., NEJM, 9/25/2019

Mechanisms Of PECAM-1 Signaling In Endothelial CellsNational Heart, Lung, And Blood Institute2000–2002